Amgen CEO Bob Bradway is using AI to find drug candidates 50% faster
By betting on genomic data a decade ago, Amgen is now navigating the high-stakes tension between self-taught AI autodidacts and irreplaceable scientific experts.
By Turki Al-Mutairi·· 3 min